Work

Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?

Year: 2020

Type: article

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2020.05.003

Authors: Jacob J. Adashek, Jarred P. Reed, Ankita Tandon, Stephen J. Freedland, Edwin Posadas, Neil Bhowmick, Leland W. Chung, Michael Freeman, Robert A. Figlin, Jun Gong

Institutions: University of South Florida, Moffitt Cancer Center, Cedars-Sinai Medical Center, Durham VA Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, Astellas Pharma US, Sanofi, Exelixis, National Institutes of Health, Johnson and Johnson, National Cancer Institute

Awards: UCLA SPORE in Prostate Cancer, G864096937

OpenAlex ID: W3023947295

FWCI: 0.984

Cites: 13

Cited by: 8

Related to: 10